Safe and Effective T Cell-Driven Therapies For Solid Tumors: A Dream Within Reach
Executive Summary
The industry has witnessed a lot of progress with cell therapies for blood cancers. The next critically important goal must be to find a safe and effective pathway for cell therapies in patients with solid tumors.
You may also be interested in...
US FDA Punts To Congress On CBD: Rx Topics Remain Outside Political Spotlight
FDA is formally asking Congress to weigh in on the best approach to regulate CBD in consumer products. That provides another target for legislative attention that may mean that FDA’s core drug regulatory activities stay comfortably out of the spotlight.
Behind A Rekindled Dream And China Biotech’s New Reality
The latest mega deals aimed at bringing Chinese innovation to the US have rekindled go-global hopes for a sector badly needing some cheer. But some investors say out-licensing may be the best route and that Chinese biotech must scale back its do-all mentality and focus on what it does best amid a new reality.
Givaudan’s AI-Powered Myrissi Allows Scents To Be Seen, Felt, Marketed
Myrissi draws on a decade of academic research in brain imagery and AI, an odor-color database of more than 25,000 consumer tests, and a wealth of affective data to translate fragrances into color patterns and images and predict the end consumer’s emotional response. The technology is targeted for use in developing fine fragrance, beauty and home-care products and marketing campaigns.